Browsing by Author Papatheodoridi, M

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 12 to 18 of 18 < previous 
TitleAuthor(s)Issue DateViews
 
Nucleos(t)ide analogue withdrawal in chronic hepatitis B patients leads to limited sustained remission in the absence of HBsAg loss: results from the RETRACT-B study. Oral Presentation.
Proceeding/Conference:The Liver Meeting 2021 (AASLD 2021), 12-15 November 2021. Hepatology
Hirode, GHansen, BEChen, C-HSu, T-HPapatheodoridi, MLens, SHees, SVBrakenhoff, SChoi, HSJChien, RNSeto, WKWWong, GLHFeld, JJChan, HLYYuen, RMFSonneveld, MJVanwolleghem, TForns, XPapatheodoridis, GKao, J-HHsu, Y-CCornberg, MCornberg, W-JJanssen, HLARETRACT-B Study Group,
2021
 
Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study)
Journal:Gastroenterology
Hirode, GChoi, HSJChen, CHSu, THSeto, WKWVan Hees, SPapatheodoridi, MLens, SABELAWong, GBrakenhoff, SMChien, RNFeld, JSonnevel, MChan, HLForns, XPapatheodoridis, GVVanwolleghem, TYuen, RMFHsu, YCKao, JHCornerg, MHansen, BEJeng, WJJanssen, HLA
2021
17
 
Prediction of sustained response after nucleo(s)tide analogue cessation using HBsAg and HBcrAg levels – a multicenter study (CREATE)
Proceeding/Conference:Hepatology
Sonneveld, MJPark, JYKaewdech, ASeto, WKWTanaka, YCarey, IPapatheodoridi, MVan Bömmel, FBerg, TZoulim, FAhn, SHDalekos, GNErier, NSHöner zu SiederdissenC, CWedemeyer, HComberg, MYuen, RMFAgarwal, KBoonstra, AFerret, MABPiratvisuth, TPapatheodoridis, GMaasoumy, BCREATE study group,
2020
12
 
Prediction Of Sustained Response After Nucleo(s)tide Analogue Cessation Using Hbsag And Hbcrag Levels – A Multicenter Study (create)
Journal:Clinical Gastroenterology and Hepatology
Sonneveld, MJPark, JYKaewdech, ASeto, WKTanaka, YCarey, IPapatheodoridi, Mvan Bommel, FBerg, TZoulim, FAhn, SHDalekos, GNErler, NSHoner zu Siederdissen, CWedemeyer, HCornberg, MYuen, MFAgarwal, KBoonstra, AButi, MPiratvisuth, TPapatheodoridis, GMaasoumy, B
2020
36
 
Predictors of HBsAg loss after cessation of nucleo (s)tide analogue therapy in asian patients with low HBsAg levels. Poster Presentation (SAT344)
Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology
Sonneveld1, MChiu, SMPark, JYKaewdech, ASeto, WKWTanaka, YCarey, IPapatheodoridi, Mvan Bömmel, FBrakenhoff, SBerg, TZoulim, FAhn, SHDalekos, GErler, NHoener zu Siederdissen, CWedemeyer1, HCornberg, MYuen, RMFAgarwa, KBoonstra, AButi, MPiratvisuth, TPapatheodoridis8, GChen, C-HMaasoumy, B
2022
1
 
Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels
Journal:Journal of Hepatology
Sonneveld, MJChiu, SMPark, JYBrakenhoff, SMKaewdech, ASeto, WKWTanaka, YCarey, IPapatheodoridi, Mvan Bommel, FBerg, TZoulim, FAhn, SHDalekos, GSErler, NSHoner zu Siederdissen, CWedemeyer, HCornberg, MYuen, RMFAgarwal, KBoonstra, AButi, MPiratvisuth, TPapatheodoridis, GChen, CHMaasoumy, B
2022
6
 
Viral and ALT kinetics after nucleos (t)ide analogue withdrawal among patients who remain off-therapy: results from a global, multi-ethnic cohort of chronic hepatitis B patients (RETRACT-B study). Poster Presentation (SAT400)
Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology
Hirode, GHansen, BChen, C-HSu, T-HPapatheodoridi, MLens, SHees, SVBrakenhoff, SChoi, SHJChien, R-NSeto, WKWWong, GFeld, JChan, HLYYuen, RMFSonneveld, MVanwolleghem, TForns, XPapatheodoridis, GKao, J-HHsu, Y-CCornberg, MJeng, R W-JJanssen, H
2022
Showing results 12 to 18 of 18 < previous